Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-050984
Filing Date
2007-03-09
Accepted
2007-03-09 16:51:26
Documents
12
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1178954
2 CONSENT, WAIVER AND AMENDMENT dex1011b.htm EX-10.11B 67845
3 AFFILIATION AGREEMENT / REGISTRATION RIGHTS AGREEMENT dex1014b.htm EX-10.14B 282129
4 INCRELEX LICENSE AND COLLABORATION AGREEMENT dex1014c.htm EX-10.14C 447406
5 SOMATULINE LICENSE AND COLLABORATION AGREEMENT dex1014d.htm EX-10.14D 403287
6 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 3695
7 CERTIFICATION OF CEO OF TERCICA, INC., AS REQUIRED BY RULE 13A-14(A) dex311.htm EX-31.1 6047
8 CERTIFICATION OF CFO OF TERCICA, INC., AS REQUIRED BY RULE 13A-14(A) dex312.htm EX-31.2 6014
9 CERTIFICATION BY THE CEO, AS REQUIRED BY RULE 13A-14(B) dex321.htm EX-32.1 3511
10 CERTIFICATION BY THE CFO, AS REQUIRED BY RULE 13A-14(B) dex322.htm EX-32.2 3479
11 GRAPHIC g54547g80r38.jpg GRAPHIC 108063
12 GRAPHIC g54547g81g49.jpg GRAPHIC 46901
  Complete submission text file 0001193125-07-050984.txt   2617598
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 6506244900
TERCICA INC (Filer) CIK: 0001262175 (see all company filings)

EIN.: 260042539 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50461 | Film No.: 07685093
SIC: 2834 Pharmaceutical Preparations